About

Mehar is a dedicated researcher in the field of molecular biology, specializing in the study of LRRK2 and its role in Parkinson’s disease. Currently a Postdoctoral Researcher at the University of Dundee in the MRC Protein Phosphorylation & Ubiquitylation Unit (PPU), Mehar is contributing to the LITE Project, focusing on kinase signaling, protein phosphorylation, and ubiquitination to develop new therapeutic strategies for neurodegenerative diseases.

Previously, Mehar's research centered on BRCA1, an E3 ligase crucial for DNA repair, and its potential role in modulating the accumulation of tau protein in Alzheimer's disease. Through rigorous experimentation and interdisciplinary collaboration, Mehar aims to uncover novel therapeutic avenues for neurodegenerative disorders, including Parkinson’s disease and Alzheimer’s.

By exploring the molecular mechanisms underlying these diseases and the roles of key proteins involved, Mehar aspires to contribute to the development of targeted interventions to improve patient outcomes and restore cognitive function.

Employment

Employment history is unavailable.

Education

Projects & Funding

Projects & funding information is unavailable.

Publications (12)